European Pharmaceutical Review

MARCH 27, 2025

A new industry survey from the Biotechnology Innovation Organization (BIO) highlights the vulnerability of supply that proposed tariffs would put on medicines, and its impact on patient access. Proposed tariffs on the EU would force half of companies to find new research and manufacturing partners.

Medicine 52

Medicine Food and Drug Administration Manufacturing Food 52

European Pharmaceutical Review

JUNE 17, 2024

A portion of the investment, €125 million, is intended to support greater production capacity at its Latina site, which is a key part of the firm’s worldwide supply chain network, the company stated. Johnson & Johnson Innovative Medicine is planning to invest a total of €580 million in Italy over the next five years.

Medicine 97

Medicine Manufacturing Management Government 97

Legacy MEDSearch

DECEMBER 21, 2022

a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the “ALICE device”) to undergo the Verification and Validation phase prior to its planned 2023 submission to the U.S. Inspira Technologies OXY B.H.N. and Israel.

Manufacturing 98

Manufacturing FDA Food and Drug Administration Medical 98

European Pharmaceutical Review

DECEMBER 30, 2024

Numerous groundbreaking advances have shown these therapies hold potential to revolutionise how we treat, and potentially cure, many conditions, including for patients with underlying genetic or cellular causes of disease that have been difficult to treat with conventionalapproaches.

Manufacturing 52

Manufacturing Food and Drug Administration Medicine Training 52

European Pharmaceutical Review

NOVEMBER 23, 2022

The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU).

Medicine 111

Medicine Networking Manufacturing Training 111

PM360

SEPTEMBER 15, 2022

PM360 asked industry experts what it takes to be a patient-first organization and how companies can better ensure they are delivering experiences that meet patients’ expectations. Specifically, we asked them: What is required today for life sciences companies to truly practice a patient-first approach? Matt Flesch.

Patients 98

Patients Education Management Side effects 98

European Pharmaceutical Review

OCTOBER 31, 2024

It pledges to benefit key industry sectors across life sciences including R&D, innovation, manufacturing and medicine. Over the last five years Made Smarter has transformed countless SME manufacturers,” stated Donna Edwards, Director of Made Smarter’s North West adoption programme.

Manufacturing 52

Manufacturing Medical science Medicine Engineering 52

Pharma Marketing Network

MARCH 12, 2025

In a highly regulated industry, choosing the right keywords can determine whether your ads reach healthcare professionals, patients, or caregivers effectively. Understanding how patients and healthcare professionals search for medical information is key. For more pharma keyword research strategies, visit Pharma Marketing Network.

Marketing 59

Marketing Pharma Prescription Competition 59

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patients 96

Patients Pharma Consulting Transportation 96

PM360

JANUARY 24, 2025

Swoop Announces Merge with MyHealthTeam Swoop, an AI-driven healthcare marketing company, has acquired MyHealthTeam, creator of one of the largest patient social networks in the United States. Novo plans to start another study in the first half of 2025 to determine how best to boost patients doses.

Networking 52

Networking Healthcare Healthcare Management 52

Pharmaceutical Technology

MAY 17, 2023

WuXi Biologics and InflaRx have entered a manufacturing partnership for advancing Gohibic (vilobelimab) to treat certain critically ill Covid-19 patients. Under the collaboration, WuXi Biologics will be responsible for providing cGMP manufacturing of Gohibic.

Manufacturing 52

Manufacturing Food and Drug Administration Networking FDA 52

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

Legacy MEDSearch

MARCH 14, 2023

The report concluded that the Company’s UroShield device showed a decrease in the number of blockages and infections and an increase in catheter satisfaction in the patients studied. UroShield is available to all NHS clinicians and their patients who need the device with full clinical support, through the NHS supply chain.

Patients 98

Patients Medical Recruitment Management 98

European Pharmaceutical Review

OCTOBER 2, 2023

Uniting the global supply chain CPHI Barcelona serves as a vital platform for unrivalled networks and access to the global supply chain. The market space offers various benefits, including promotion as a show feature, access to start-up mentors, and a dedicated start-up networking lounge. Manufacturing Excellence 5.

Manufacturing 105

Manufacturing Pharma Engineering Networking 105

European Pharmaceutical Review

APRIL 4, 2024

Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. The funding will start with three established Centres, and then across an expanded network, according to Chief Clinical Officer for Cell and Gene Therapy Catapult, Jacqueline Barry.

Networking 98

Networking Training Recruitment Healthcare 98

Pharmaceutical Technology

MARCH 24, 2023

Takeda has unveiled plans to invest almost $764m (JPY100bn) to construct a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. The new facility represents the company’s largest-ever investment in the expansion of manufacturing capacity in the country.

Manufacturing 52

Manufacturing Networking Patients Pharma 52

pharmaphorum

JANUARY 22, 2023

A well-designed and thought-out digital solution, with a considered user experience, can deliver a better service and support HCPs to deliver positive patient outcomes, whilst strengthening relationships between pharma companies and their HCP networks. How can this impact patient care? What is meant by an HCP portal?

Pharma 98

Pharma Patients Marketing Distribution 98

European Pharmaceutical Review

JUNE 13, 2023

ITM Isotope Technologies Munich SE ( ITM )’s manufacturing plant in Neufahrn near Munich will produce the innovative medical isotope for targeted cancer therapies. “Radiopharmaceuticals are an essential new class of anti-cancer drugs that have the potential to improve therapy outcomes and quality of life for many patients.

Manufacturing 105

Manufacturing Networking Medical Pharma 105

European Pharmaceutical Review

FEBRUARY 9, 2024

Under the terms of the agreement, BioNTech will pay $50 million to Autolus, granting the immunotherapy company rights including the option to access Autolus’ commercial and clinical site network, manufacturing capacities in the UK and commercial supply infrastructure.

Networking 111

Networking Manufacturing Sales Leads 111

European Pharmaceutical Review

DECEMBER 7, 2023

A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.

Networking 98

Networking Medicine Leads Manufacturing 98

Impetus Digital

JANUARY 30, 2023

Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.

Pharmaceutical 67

Pharmaceutical Patients Safety Medical 67

European Pharmaceutical Review

AUGUST 31, 2023

Cancer patients critically depend on accurate diagnosis and disease treatment. By reaching cancer cells that have already spread throughout the body, a targeted radiopharmaceutical treatment offers an alternative for patients with advanced cancer when standard lines of treatment, such as chemotherapy, have failed.

Food and Drug Administration 97

Food and Drug Administration Manufacturing Safety Transportation 97

European Pharmaceutical Review

NOVEMBER 8, 2022

Sandoz , a leading antibiotics producer has announced its €50 million investment to increase Europe’s manufacturing capacity of finished dosage form (FDF) penicillin, the most common form of antibiotic worldwide, to enhance global manufacturing capacity of amoxicillin and other major penicillin products.

Manufacturing 52

Manufacturing Networking Pharmaceutical Medicine 52

European Pharmaceutical Review

AUGUST 15, 2023

The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region. “We expect a large international attendance and will marry this with local and regional manufacturing insights.”

Manufacturing 98

Manufacturing Pharma Pharmaceutical Pharmaceutical research 98

Pharmaceutical Technology

MAY 18, 2023

Within the 14-page document , published by an EMA special task force, are 10 recommendations of best practices that “marketing authorisation holders, wholesalers, distributors, and manufacturers can consider adopting to ensure continuity of medicinal product supply and reduce the impact of shortages”.

Medicine 99

Medicine Specialization Networking Patients 99

Legacy MEDSearch

FEBRUARY 26, 2025

tariffstargeting imports from key manufacturing hubs like China, Mexico, and Canadais set to introduce new challenges that will reshape the landscape of medical device sales and manufacturing in 2025. based manufacturers relying on imported parts. A core objective of these tariffs is to bring more manufacturing back to the U.S.,

Manufacturing 52

Manufacturing Medical Sales Healthcare Provider 52

European Pharmaceutical Review

SEPTEMBER 15, 2022

The investment is part of the company’s global effort to implement the most innovative technologies and most sustainable processes at its manufacturing sites. They are used for the treatment of patients with complex diseases, such as primary or acquired immunodeficiencies, or rare diseases like hereditary angioedema and bleeding disorders.

Manufacturing 98

Manufacturing Training Patients Networking 98

pharmaphorum

OCTOBER 12, 2022

By remaining compliant, medicines are manufactured in line with their pre-defined and approved specifications, in order to ensure the delivery of safe and effective products to consumers. So, with mandates in place, how do manufacturing facilities meet these compliance goals? Cybersecurity and non-conformance.

Manufacturing 105

Manufacturing Medicine Leads Distribution 105

Pharmaceutical Representative Training

MARCH 17, 2025

Healthcare professionals are also catching up to the patient group, which has long been engaged on social media. It can be applied to comprehend patient difficulties and spot chances for clinical intervention. Patient and healthcare professionals anticipate personalized, communication based on value.

Media 52

Media Sales Pharma Healthcare 52

PM360

SEPTEMBER 30, 2024

These advancements can enhance drug solubility and bioavailability, improve the speed to clinical trials, reduce environmental impact, and increase patient access to treatments. This uncovers opportunities to implement green chemistry principles, overhaul inefficient manufacturing techniques, and modernize outdated methods.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

pharmaphorum

JANUARY 27, 2023

Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients out of “at least $100 million.”

Insurance 105

Insurance Medicine Patients Prescription 105

Pharmaceutical Technology

JUNE 29, 2022

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

Pharmaceutical Technology

SEPTEMBER 7, 2022

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.

Leads 52

Leads Pharmaceutical Patients Pharmaceutical manufacturing 52

European Pharmaceutical Review

SEPTEMBER 25, 2023

ERP systems and drug serialisation As the scale of generating serialising products is minimal, small manufacturers can alter or improve their current Base ERP system and develop an internal serialisation process. This can be measured by success factors of systems that have been successfully implemented and their interactions.”

Pharmaceutical 105

Pharmaceutical Pharmacology Safety Manufacturing 105

Pharmaceutical Technology

MAY 24, 2023

The ability to modify or introduce genetic material in human cells in such a precise and patient-centered manner clearly constitutes a breakthrough in personalized medicine. Allogeneic therapies begin with healthy donor samples to develop the eventual therapeutic product which can be administered to multiple patients.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

Impetus Digital

AUGUST 2, 2024

From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. Among others, ML algorithms can predict trial outcomes, write protocols, optimize eligibility criteria, identify and recruit the most suitable candidates for trials, monitor patient health remotely, and analyze data.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

Pharmaceutical Technology

JANUARY 20, 2023

As witnessed during the Covid-19 pandemic, when supply chains are disrupted, getting supplies and treatments to patients becomes a major issue. Reaching patients can be difficult if roads are washed away, ships can’t leave ports or planes can’t take off due to volatile weather conditions.

Pharma 142

Pharma Pharmaceutical Manufacturing Distribution 142